AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer's disease and pain, today announced that an abstract on its preclinical project TrkA-NAM against osteoarthritis pain and other severe pain conditions has been accepted for presen...
Related Keywords
Sweden , Swedish , Azita Rasti , Johan Sandin , Alzecure Pharma , Cristina Parrado Fernandez , Gunnar Nordvall , Pontus Forsell , Maria Backlund , Asahi Kasei , Veronica Lidell , World Congress On Pain , Pharmacological Effects , Selective Negative Allosteric Modulator , Nasdaq First North Premier Growth Market ,
vimarsana.com © 2020. All Rights Reserved.